Successful treatment of acute promyelocytic leukemia accompanied by serious subdural hematoma

Internal Medicine

Volumn 51, Issue 16, 2012, Pages 2209-2212

  Ichikawa, Satoshi ^a,b   Suzuki, Takuma ^a   Kimura, Jun ^a   Harigae, Hideo ^b  

^a Yamagata City Hospital Saiseikan   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute promyelocytic leukemia; Chronic subdural hematoma; Disseminated intravascular coagulation

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CD33 ANTIGEN; CEFEPIME; CYTARABINE; DEXAMETHASONE; DORIPENEM; FIBRINOGEN; FRESH FROZEN PLASMA; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IDARUBICIN; IMMUNOGLOBULIN; MEROPENEM; METHOTREXATE; MICAFUNGIN; MICROSOMAL AMINOPEPTIDASE; RECOMBINANT THROMBOMODULIN; RETINOIC ACID;

ADULT; ARTICLE; BONE MARROW EXAMINATION; BRAIN HERNIA; CASE REPORT; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOPENIA; DISSEMINATED INTRAVASCULAR CLOTTING; DROWSINESS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE; HEADACHE; HUMAN; LEUKEMIA REMISSION; MENINGITIS; MULTIPLE CYCLE TREATMENT; PLASMA TRANSFUSION; PML RARA GENE; PROMYELOCYTIC LEUKEMIA; SUBDURAL HEMATOMA; SURGICAL DRAINAGE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CONSOLIDATION CHEMOTHERAPY; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; INDUCTION CHEMOTHERAPY; LEUKEMIA, PROMYELOCYTIC, ACUTE; MIDDLE AGED; REOPERATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84865118834     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7935     Document Type: Article

References (11)

1. Arber DA, Brunning RD, Le Beau MM, et al. Acute myeloid leukemia with recurrent genetic abnormalities. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer. Lyon, France, 2008: 110-123.
2. Asou N, Kishimoto Y, Kiyoi H, et al. A randomized study with orwithout intensified maintenance chemotherapy in patients withacute promyelocytic leukemia who have become negative forPML-RARα transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study. Blood 110: 59-66, 2007.
3. Breen KA, Grimwade D, Hunt BJ. The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia. Br J Haematol 156: 24-36, 2012.
4. Sanz MA, Grimwade D, Tallman MS, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 113: 1875-1891,2009.
5. Yanada M, Matsushita T, Asou N, et al. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome. Eur J Haematol 78: 213-219, 2007.
6. Chung CY, Hsu NC, Horng HC, Chang CS. Successful treatment for multiple cerebral hemorrhage in a newly diagnosed patient with acute promyelocytic leukemia. Leuk Lymphoma 44: 1059-1061, 2003.
7. Okubo C, Kanamori H, Sasaki H, et al. Successful treatment of subdural hematoma with operation in a patient with acute promyelocytic leukemia. Rinsho Ketsueki 38: 539-543, 1997 (in Japanese).
8. Yamaji S, Kanamori H, Tanaka M, et al. Successful emergency operation for subdural hematoma and acute epidural hematoma in a patient with acute promyelocytic leukemia. Rinsho Ketsueki 40: 606-609, 1999 (in Japanese).
9. Macheta MP, Shun JK, Yin JA. Central nervous system relapse of acute promyelocytic leukaemia in a patient with cerebral haemorrhage at diagnosis. Br J Haematol 114: 954-955, 2001.
10. Grudeva-Popova J, Yaneva M, Zisov K, Ananoshtev N. Therapyrelated acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review. J BUON 12: 129-132, 2007.
11. Hall P, Boice JD, Berg G, et al. Leukaemia after iodine-131 exposure. Lancet 340: 1-4, 1992.